Assessment of androgen receptor function in genital skin fibroblasts using a recombinant adenovirus to deliver an androgen-responsive reporter gene.
Mutations of the androgen receptor (AR) cause defects in virilization and can result in a spectrum of phenotypic abnormalities of male sexual development that includes patients with a completely female phenotype (complete testicular feminization) and individuals with less severe defects of virilization, such as Reifenstein syndrome. These phenotypes are not specific for mutations of the AR gene, however, and defects in other genes can also result in similar abnormalities of male development. For this reason, the diagnosis of an AR defect is laborious and requires data from endocrine studies, the family history, and in vitro binding experiments. To assist in the evaluation of patients with possible AR defects, we previously employed the use of a recombinant adenovirus to deliver an androgen-responsive gene into fibroblast cultures to assay AR function in normal subjects and patients with complete forms of androgen resistance. Although these studies demonstrated measurable differences between these two groups of subjects, we did not assay samples from patients with partial defects of androgen action. In the current study, we have modified this method to examine AR function in three groups of patients with known or suspected defects of AR function: patients with Reifenstein syndrome, patients with spinobulbar muscular atrophy, and patients with severe forms of isolated hypospadias. When assayed using this method, the AR function of patients with Reifenstein syndrome was intermediate between that of normal control subjects and that of patients with complete testicular feminization. Using the parameters established by the aforementioned experiments, we found that defective AR function can be detected in fibroblasts established from patients with spinobulbar muscular atrophy and in some patients with severe forms of isolated hypospadias, including two with a normal AR gene sequence. These results suggest that this method may have some utility in screening samples to detect defects of AR function, particularly when viewed in the context of other AR assays results.
McPhaul
M J
MJ
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235, USA.
Schweikert
H U
HU
Allman
D R
DR
D000256:Adenoviridae / Q000235:genetics*; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D017930:Genes, Reporter; D005835:Genitalia; D006801:Humans; D007021:Hypospadias / Q000378:metabolism; D008297:Male; D009134:Muscular Atrophy, Spinal / Q000378:metabolism / Q000473:pathology; D011944:Receptors, Androgen / Q000502:physiology*; D011995:Recombination, Genetic; D012016:Reference Values; D012867:Skin / Q000166:cytology / Q000378:metabolism*; D013577:Syndrome; D014770:Virilism / Q000378:metabolism / Q000473:pathology
D011944:Receptors, Androgen